Succinate stimulates interleukin 25 (IL25) production through this receptor, thereby inducing a type 2 immune response, which is associated with the activation of type 2 naïve lymphoid cells (ILC2), eosinophilia, and increased TC and goblet cell differentiation [62]. This evidence concerns the gene IL25 and Increased total eosinophil count.